Answer
Concomitant use of fezolinetant with oestrogen hormone replacement therapy, excluding local vaginal preparations, is not recommended because it has not been studied.
Sources for this answer
- Veoza 45 mg film-coated tabletsAstellas Pharma Ltd · emc · SmPC §4.4 Special warnings and precautions for use · Version 5Document updated
Sources checked